Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RAGE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | RAGE |
| Aliases | Receptor for Advanced Glycation End Products |
| Protein Type | Receptor |
| Function | In the healthy nervous system, RAGE participates in: - Development: Neuronal differentiation and migration during embryonic development - Repair: Tissue repair and regeneration following injury - Infl |
| Primary Expression | hippocampus, cortex, spinal cord, Thalamus, Hypothalamus |
| Molecular Weight | 45 kDa |
| Pathways | NF-κB, MAPK pathway, NF-κB signaling |
| GeneCards | RAGE |
| Human Protein Atlas | RAGE |
| Advanced Glycation End-products (AGEs) | Products of non-enzymatic glycation that accumulate with aging and diabetes |
| HMGB1 | High mobility group box 1 protein released from damaged cells |
| S100 proteins | Calcium-binding proteins released during inflammation |
| Phosphatidylserine | Exposed on apoptotic cells[@bianchi2011] |
| [NF-κB](/entities/nf-kb) pathway | Leads to increased expression of inflammatory cytokines |
| MAPK pathways | Including p38, JNK, and ERK |
| Associated Diseases | ALS, Aging, Alzheimer, Atherosclerosis, Cancer |
| Known Drugs/Compounds | RAPAMYCIN, RESVERATROL, resveratrol, metformin |
| Interactions | TLR4, CD14, CD47, CMKLR1, TLR2, APP |
| KG Connections | 1090 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
HMGB1["HMGB1<br/>Damage-Associated<br/>Molecular Pattern"] --|"activates"|--> RAGE["RAGE<br/>Receptor for Advanced<br/>Glycation End Products"]
AGEs["AGEs<br/>Advanced Glycation<br/>End Products"] --|"binds"|--> RAGE
Amyloid["Amyloid-beta<br/>Peptides"] --|"binds"|--> RAGE
RAGE --|"activates"|--> NF_kB["NF-kappaB<br/>Transcription Factor"]
RAGE --|"activates"|--> Cathepsin_B["Cathepsin B<br/>Lysosomal Protease"]
NF_kB --|"promotes"|--> Neuroinflammation["Neuroinflammation<br/>Microglial Activation"]
NF_kB --|"induces"|--> Cytokines["Pro-inflammatory<br/>Cytokines<br/>(TNF-alpha, IL-1beta)"]
Neuroinflammation --|"contributes_to"|--> Alzheimer["Alzheimer's Disease<br/>Neurodegeneration"]
Neuroinflammation --|"contributes_to"|--> ALS["ALS<br/>Motor Neuron<br/>Degeneration"]
Neuroinflammation --|"contributes_to"|--> MS["Multiple Sclerosis<br/>Demyelination"]
RAGE --|"activates"|--> Oxidative_Stress["Oxidative Stress<br/>ROS Production"]
Oxidative_Stress --|"damages"|--> Neurons["Neuronal Cells<br/>Synaptic Loss"]
RAGE_Inhibitors["RAGE Antagonists<br/>Therapeutic Compounds"] --|"inhibits"|--> RAGE
Neurons --|"leads_to"|--> Neurodegeneration["Neurodegeneration<br/>Cognitive Decline"]
style RAGE fill:#006494
style RAGE_Inhibitors fill:#1b5e20
style Neuroinflammation fill:#ef5350
style Oxidative_Stress fill:#ef5350
style NF_kB fill:#4a1a6b
style Neurodegeneration fill:#5d4400
style Alzheimer fill:#5d4400
style ALS fill:#5d4400
style MS fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | inhibits | disease | 1.00 |
| NF-κB | activates | pathway | 0.87 |
| Neuroinflammation | inhibits | disease | 0.85 |
| cathepsin B | activates | protein | 0.80 |
| microglia | activates | cell_type | 0.80 |
| blood-brain barrier | participates_in | pathway | 0.80 |
| endothelial cells | expressed_in | cell_type | 0.80 |
| Aβ | binds_to | protein | 0.80 |
| Als | interacts_with | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Alzheimer | inhibits | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Atherosclerosis | associated_with | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | inhibits | disease | 0.75 |
| HMGB1 | expressed_in | gene | 0.70 |
| neuroinflammation | activates | disease | 0.70 |
| neuroinflammation | inhibits | disease | 0.70 |
| neurodegeneration | associated_with | disease | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| Oxidative Stress | inhibits | pathway | 0.70 |
| Nf-Κb | activates | pathway | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| NEUROINFLAMMATION | inhibits | gene | 0.70 |
| unfolded protein response | participates_in | pathway | 0.70 |
| diabetes | associated_with | disease | 0.70 |
| NF-kB signaling | participates_in | pathway | 0.70 |
| hippocampus | expressed_in | brain_region | 0.70 |
| microglia | expressed_in | cell_type | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| STING | treats | gene | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Ms | contributes_to | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| AGEs | binds_to | protein | 0.90 |
| HMGB1 | activates | protein | 0.80 |
| PTGS2 | therapeutic_target | gene | 0.80 |
| CYTOKINES | activates | gene | 0.80 |
| TNF | associated_with | gene | 0.74 |
| CASP3 | associated_with | gene | 0.74 |
| TP53 | therapeutic_target | gene | 0.70 |
| AKT1 | therapeutic_target | gene | 0.70 |
| EGFR | therapeutic_target | gene | 0.70 |
| TNF | therapeutic_target | gene | 0.70 |
| JUN | therapeutic_target | gene | 0.70 |
| MMP2 | therapeutic_target | gene | 0.70 |
| MMP9 | therapeutic_target | gene | 0.70 |
| CASP3 | therapeutic_target | gene | 0.70 |
| SPP1 | therapeutic_target | gene | 0.70 |
| PI3K | regulates | gene | 0.70 |
| AKT | regulates | gene | 0.70 |
| MTOR | activates | gene | 0.70 |
| HMGB1 | inhibits | gene | 0.70 |
| CANCER | associated_with | gene | 0.70 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| OXIDATIVE STRESS | inhibits | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| IL-6 | inhibits | gene | 0.70 |
| TNF-Α | inhibits | gene | 0.70 |
| GENES | therapeutic_target | gene | 0.70 |
| AMYLOID | associated_with | protein | 0.66 |
| MICROGLIA | associated_with | cell_type | 0.66 |
| PARKIN | causes | gene | 0.65 |
| MMP2 | causes | gene | 0.65 |
| LRP1 | regulates | gene | 0.65 |
| MMP2 | associated_with | gene | 0.65 |
| PARKIN | regulates | gene | 0.65 |
| CANCER | expressed_in | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| ALZHEIMER | causes | disease | 0.65 |
| PARKINSON | causes | disease | 0.65 |
| CANCER | regulates | disease | 0.65 |
| ERK | activates | gene | 0.65 |
| NEURODEGENERATION | regulates | disease | 0.65 |
| PARKINSON | regulates | disease | 0.65 |
| IL-18 | activates | gene | 0.65 |
| ASTROCYTE | regulates | cell_type | 0.65 |
| ASTROCYTES | regulates | cell_type | 0.65 |
| AMPK | targets | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro | 0.424 | neurodegeneration | What are the mechanisms by which gut mic |
Scientific analyses that reference this entity
spatial memory | 2026-04-08 | 0 hypotheses
neurodegeneration | 2026-04-02 | 0 hypotheses
neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.617
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Decoding cell death signals in liver inflammation. [PMID:23567086] | Brenner C, Galluzzi L, Kepp O, Kroemer G | J Hepatol | 2013 | 1 |
| Wnt-dependent modulation of alveolar epithelial phenotypes and barrier function [PMID:41678947] | Lin YC, Igarashi M, Sakai Y, Nishikawa M | Biochem Biophys Res Commun | 2026 | 0 |
| Luteolin targets the AGE-RAGE signaling to mitigate inflammation and ferroptosis [PMID:38917486] | Zhang N, Chen P, Liang X, Sun J, Liu Q, | Aging | 2024 | 0 |
| Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic li [PMID:38297127] | Fan W, Adebowale K, Váncza L, Li Y, Rabb | Nature | 2024 | 0 |
| Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming a [PMID:36154605] | ["Koerich S", "Parreira G", "de Almeida | Current neuropharmacology | 2023 | 0 |
| Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR [PMID:37442582] | Strickson S, Houslay KF, Negri VA, Ohne | The European respiratory journ | 2023 | 0 |
| Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 [PMID:34130712] | ["MacLean M", "Juranek J", "Cuddapah S", | Journal of neuroinflammation | 2021 | 0 |
| Bi-allelic loss of function variants in SLC30A5 as cause of perinatal lethal car [PMID:33547425] | Lieberwirth JK, Joset P, Heinze A, Hents | European journal of human gene | 2021 | 0 |
| Environmental Regulation, Technological Innovation, and Export Competitiveness: [PMID:32102174] | Liu J, Xie J | International journal of envir | 2020 | 0 |
| Predicting Subjective Recovery from Lower Limb Surgery Using Consumer Wearables. [PMID:33442582] | Karas M, Marinsek N, Goldhahn J, Foschin | Digital biomarkers | 2020 | 0 |
| Glycation & the RAGE axis: targeting signal transduction through DIAPH1. [PMID:27967251] | ["Shekhtman A", "Ramasamy R", "Schmidt A | Expert review of proteomics | 2017 | 0 |
| The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases. [PMID:29259621] | ["Senatus L", "Schmidt A"] | Frontiers in genetics | 2017 | 0 |
| Diabetes and Alzheimer's disease crosstalk. [PMID:26969101] | Baglietto-Vargas D, Shi J, Yaeger DM, Ag | Neuroscience and biobehavioral | 2016 | 0 |
| Pathophysiological Links Among Hypertension and Alzheimer's Disease. [PMID:26054481] | Carnevale D, Perrotta M, Lembo G, Trimar | High blood pressure & cardiova | 2016 | 0 |
| High-fructose intake as risk factor for neurodegeneration: Key role for carboxy [PMID:26851500] | ["Mastrocola R", "Nigro D", "Cento A", " | Neurobiology of disease | 2016 | 0 |
| [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for c [PMID:25486663] | Barbezier N, Tessier FJ, Chango A | Annales de biologie clinique | 2014 | 0 |